Abstract
Traditional use and clinical reports suggest that the culinary herb sage (Salvia officinalis) may be effective for patients with mild to moderate Alzheimer's disease (AD). In this study, we evaluated the effect of a standardized extract from the leaves of S. officinalis (SOE) and its active ingredient rosmarinic acid on Alzheimer amyloid-β peptide (Aβ)-induced toxicity in cultured rat pheochromocytoma (PC12) cells. Incubation of PC12 cells with Aβ (fragment 1–42) for 24 h caused cell death, and this effect was reduced by SOE and its active ingredient, rosmarinic acid. Rosmarinic acid reduced a number of events induced by Aβ. These include reactive oxygen species formation, lipid peroxidation, DNA fragmentation, caspase-3 activation, and tau protein hyperphosphorylation. Moreover, rosmarinic acid inhibited phosphorylated p38 mitogen-activated protein kinase but not glycogen synthase kinase 3β activation. These data show the neuroprotective effect of sage against Aβ-induced toxicity, which could validate the traditional use of this spice in the treatment of AD. Rosmarinic acid could contribute, at least in part, for sage-induced neuroprotective effect.
Footnotes
-
This work was supported by Cofinanziamento Murst (PRIN).
-
doi:10.1124/jpet.105.099317.
-
ABBREVIATIONS: AD, Alzheimer's disease; Aβ, amyloid-β peptide; NFT, neurofibrillary tangle(s); MAP, mitogen-activated protein; SOE, standardized extract from the leaves of Salvia officinalis; p-p38, phosphorylated p38; PC12, pheochromocytoma cells; Aβ42, amyloid β-peptide fragment 1 to 42; GSK-3β, glycogen synthase kinase 3β; TDZD-8, 4-benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione; NGF, nerve growth factor; ROS, reactive oxygen species; MTT, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium; DCF, dichlorofluorescein; PBS, phosphate-buffered saline; RFU, relative fluorescence units; MDA, malonyl dialdehyde.
- Received December 1, 2005.
- Accepted February 16, 2006.
- The American Society for Pharmacology and Experimental Therapeutics
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|